Pharmaceutical

BARDA and Tiba Biotech link to develop ‘flu therapeutics

Preclinical biopharmaceutical company Tiba Biotech has announced a partnership with BARDA to develop therapeutics against influenza.

Jul 12, 2024 - 04:00
BARDA and Tiba Biotech link to develop ‘flu therapeutics
Preclinical biopharmaceutical company Tiba Biotech has announced a partnership with BARDA to develop therapeutics against influenza.
Read the original article

Tags:

Previous Article

Respiratory bacteria ‘turns off’ immune system to survive

Next Article

J&J asserts its place in atopic dermatitis space with Yellow Jersey acquisition

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA grants RMAT designation to Taysha’s Rett syndrome gene therapy 

FDA grants RMAT designation to Taysha’s Rett syndrome g...

May 5, 2024

STAT+: More than 200 FDA staffers have retired in less than a year

STAT+: More than 200 FDA staffers have retired in less ...

Jun 6, 2023

Crossject secures funding from French Government for needle-free platform

Crossject secures funding from French Government for ne...

Jul 14, 2024